Patient care navigation and health copilot AI
RTHM
RTHM documents controls to dismiss suspected diagnoses and delete conversations. These provide practical ways to redirect the service, with deletion exceptions and model-use conditions still relevant. Clinical interpretation and underlying record correction remain separate questions.
Checklist assessment dated October 30, 2026. Independent confirmation is incomplete. Hugo has not personally verified this service.
Agency checklist · October 30, 2026
Mixed 6 of 12 yes
Document-based draft. Independent confirmation is incomplete. Hugo has not personally verified this service.
Assessed function: RTHM intelligence platform (AI assistant 'Ana', record analysis, optional HIE record retrieval); RTHM Clinic telehealth and prescribing assessed only where it touches the AI platform
A no can mean missing documentation or institution-dependent control; it does not by itself establish harmful behavior. These categories are not clinical safety or product-quality ratings.
- Public documents do not establish actual product behavior.
- The independent review screened rules and selected evidence; it did not replicate all twelve answers for this tool.
See all twelve answers and their evidence
| Question | Answer | Evidence / review | Source and reasoning |
|---|---|---|---|
| 1. Told it is AI | Yes | documented Not independently replicated | are generated by artificial intelligence (AI) systemsSource Beta Program and AI Disclosure; Terms section 6 also names the AI navigation assistant 'Ana'. |
| 2. Operator and model maker named | No | not-documented Not independently replicated | Quotation not recorded; evidence repair pending. Source RTHM, Inc. is named. The Sick Times quotes a co-founder saying the platform is built on 'general AI models', with no maker named on RTHM pages. |
| 3. Patient chooses to use it | Yes | documented Not independently replicated | Signing up and interacting with the RTHM intelligence platform is free.Source Patient signs up. Support: 'When you decide to level up your care by ordering a medication or lab via RTHM or joining the RTHM Clinic, you will be prompted to pay'. |
| 4. Patient sets the task | No | documented Not independently replicated | gathers information about you through a chat feature to provide personalized guidance about the medications available through RTHMSource Terms section 6. The AI is documented as steering toward RTHM's own medications and clinic. |
| 5. Patient can decline or stop | Yes | documented Not independently replicated | Signing up and interacting with the RTHM intelligence platform is free.Source Self-started rule applied (cites question 3 source). The Sick Times: RTHM's telehealth service 'is separate from its intelligence platform'. Whether prescribing intake requires using Ana is not documented. |
| 6. Patient sees the AI output | Yes | documented Not independently replicated | You can view your chat history in your account and delete specific conversations if desired.Source Support FAQ. Suspected diagnoses are also listed in the account. |
| 7. Patient can correct or challenge | Yes | documented Not independently replicated | These are listed for your review; you can manually confirm them if they are established diagnoses or dismiss them if they are inaccurate.Source Applies to suspected diagnoses flagged by analysis. A route to contest chat answers is not documented. |
| 8. Patient can get a copy | No | not-documented Not independently replicated | Quotation not recorded; evidence repair pending. Source Support says clinic patients can 'download your clinical data' (clinic scope). No export of platform AI output or uploaded records is documented. |
| 9. Patient can delete | Yes | documented Not independently replicated | This will remove your profile and personal data from our systemsSource Support: Delete Account in Profile settings; 'some clinical assessment records must be retained for legal compliance'. |
| 10. Training or sale does not override patient choice | No | documented Not independently replicated | may be used by RTHM or Medical Group to train, develop, enhance, evolve and improve the Service and the underlying AI modelsSource Terms (User Information license). Privacy says Google Health wearable data is not used to train generalized models, but no general opt-out. Support says data is used to 'improve the service'. |
| 11. Patient can run it or take it elsewhere | No | not-documented Not independently replicated | Quotation not recorded; evidence repair pending. Source Vendor-hosted only. |
| 12. No advertising or data business | No | documented Not independently replicated | may disclose, aggregate, sell, or otherwise use such de-identified information to third parties for analytics, research, or other purposesSource Terms also allow use 'for marketing and promotional purposes'. Privacy: Google Ads remarketing and advertising-network targeting. Support says 'We do not sell your data to third parties', which conflicts with Terms on de-identified data; answered by binding Terms. |
Initial coding: Claude Sonnet helpers, compiled by Claude Opus 5.5 (Anthropic). Selective review and corrections: GPT-6 Astra (OpenAI). Editor: Hugo Campos. Acceptance of corrections is not product verification.
Checklist rules · Independent review and limitations · Later evidence follow-up
Earlier v1.3 assessment and control finding
Historical assessment under different rules. It does not set the current checklist zone.
Agency finding, before method v1.3
Potentially agency-expanding, with vendor-funnel and data-use caveats
Legacy editorial placement, pre-method: 70
This profile has not yet been reviewed under the published method. Its finding and any number are editorial placements made before the method existed.
- Evidence
- Documentary review. Public sources only, no hands-on testing by HugoScore.
- Review status
- AI draft. No person has settled the findings.
Earlier evidence and assessment
The sections below preserve the earlier review. Its classifications and provenance are historical; the checklist above gives the current draft classification.
Earlier finding · Legacy editorial placement, pre-method: 70
Method v1.3. The control line is evidence for how the agency finding arose, not a quality score. Legacy editorial placement, pre-method: 70. Not comparable with v1.3 positions.
Potentially agency-expanding, with vendor-funnel and data-use caveats
RTHM documents controls to dismiss suspected diagnoses and delete conversations. These provide practical ways to redirect the service, with deletion exceptions and model-use conditions still relevant. Clinical interpretation and underlying record correction remain separate questions.
Patient agency
How this tool changes agency
Organizing history and preparing questions can strengthen patient action. Profile correction is now documented, although source-linked review of every roadmap recommendation remains unverified.
Practical roadmap editing, source provenance, consent clarity and paid-care recommendation influence remain unverified
Patient agency assessment
Who sets and changes the goal?
The ability to dismiss a suspected diagnosis is substantive control over the platform's representation of the patient. Optional HIE participation and care-team sharing provide further choices.
What can the patient understand, question, or do?
Organizing history and preparing questions can strengthen patient action. Profile correction is now documented, although source-linked review of every roadmap recommendation remains unverified.
Can the patient evaluate the conditions of use?
The FAQ explains reciprocal HIE exchange and its alternative. Training and derivative-use permissions remain material conditions despite simplified no-sale wording.
Text findings
Conditions of use
Published controls and their limits
The FAQ explains reciprocal HIE exchange and its alternative. Training and derivative-use permissions remain material conditions despite simplified no-sale wording.
What remains unknown?
Not tested or not established
Practical roadmap editing, source provenance, consent clarity and paid-care recommendation influence remain unverified
Who evaluated this?
AI-assisted public-source draft
Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.
Sources checked
Source-specific findings and retrieval limitations are recorded in the full report.
Earlier review provenance
Criteria
CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.
Reviewer
AI-assisted public-source reassessment prepared in OpenAI Codex.
AI / model
OpenAI Codex / GPT-6
Human review
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
Review date
2026-09-08
Limitations
Practical roadmap editing, source provenance, consent clarity and paid-care recommendation influence remain unverified No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.
Earlier review method
Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
Document-based draft · Moderate for published controls and terms (AI-assisted draft)